Jason is part of Alexion Pharmaceuticals R&D based in New Haven, Connecticut. Alexion’s exclusive focus is on ultra-rare disease therapies. At Alexion he is responsible for R&D project planning, risk assessment, and continuous improvement of portfolio, project, and resource management tools and processes. Jason is a Six Sigma Black Belt, and a PMI (PMP, RMP, and SP) credential holder who started his career as a bench scientist prior to moving into business process optimization and project management.Prior to Alexion Jason was with Medtronic, Siemens Healthcare, and Bayer Healthcare.